Scale Up: Bringing Nanomedicine From The Lab To The Clinic

COVID-19 has been a microcosm for the urgent necessity to move nanomedicines that are developed in the lab to the clinic. Rapid, safe and effective scale up methods are becoming increasingly necessary to meet the demands of the population. Here, we discuss key components and common pain points of scaling up nanomedicine production and use recent publications to walk customers through the process.